Savaria Co. (TSE:SIS - Free Report) - Equities researchers at Desjardins lowered their Q3 2024 EPS estimates for Savaria in a research note issued on Monday, October 21st. Desjardins analyst F. Tremblay now forecasts that the company will post earnings of $0.18 per share for the quarter, down from their prior estimate of $0.19. Desjardins currently has a "Buy" rating and a $26.00 target price on the stock. The consensus estimate for Savaria's current full-year earnings is $1.20 per share. Desjardins also issued estimates for Savaria's FY2025 earnings at $1.11 EPS.
Savaria (TSE:SIS - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported C$0.22 EPS for the quarter, beating analysts' consensus estimates of C$0.20 by C$0.02. Savaria had a return on equity of 8.95% and a net margin of 5.25%. The firm had revenue of C$221.34 million for the quarter, compared to analyst estimates of C$213.08 million.
A number of other brokerages also recently issued reports on SIS. Raymond James boosted their price target on shares of Savaria from C$25.00 to C$27.50 and gave the stock an "outperform" rating in a research report on Friday, September 13th. Scotiabank set a C$25.00 price target on Savaria and gave the stock an "outperform" rating in a report on Thursday, September 26th. Stifel Nicolaus boosted their price objective on Savaria from C$24.00 to C$25.00 and gave the company a "buy" rating in a research note on Tuesday, August 20th. TD Securities raised their target price on Savaria from C$23.00 to C$24.00 and gave the stock a "buy" rating in a research note on Thursday, August 8th. Finally, National Bankshares boosted their price target on Savaria from C$22.00 to C$27.00 and gave the company an "outperform" rating in a research note on Thursday. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat, Savaria presently has an average rating of "Buy" and an average price target of C$25.50.
Get Our Latest Stock Report on Savaria
Savaria Price Performance
The company has a market capitalization of C$1.61 billion, a PE ratio of 34.91, a PEG ratio of 42.72 and a beta of 0.90. The firm has a 50 day moving average of C$21.21 and a 200 day moving average of C$19.00. The company has a debt-to-equity ratio of 56.50, a current ratio of 1.94 and a quick ratio of 0.91. Savaria has a twelve month low of C$12.21 and a twelve month high of C$23.92.
Insider Activity
In related news, Director Jean-Louis Chapdelaine sold 25,000 shares of the stock in a transaction on Tuesday, September 17th. The stock was sold at an average price of C$20.84, for a total value of C$521,000.00. In other Savaria news, Senior Officer Sylvain Aubry sold 20,002 shares of the business's stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of C$20.75, for a total transaction of C$415,041.50. Also, Director Jean-Louis Chapdelaine sold 25,000 shares of the stock in a transaction that occurred on Tuesday, September 17th. The stock was sold at an average price of C$20.84, for a total value of C$521,000.00. Insiders sold a total of 50,002 shares of company stock worth $1,046,042 over the last quarter. 17.45% of the stock is currently owned by corporate insiders.
Savaria Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Tuesday, November 12th. Shareholders of record on Thursday, October 31st will be paid a $0.045 dividend. The ex-dividend date is Thursday, October 31st. This represents a $0.54 dividend on an annualized basis and a yield of ∞. Savaria's dividend payout ratio (DPR) is presently 83.08%.
Savaria Company Profile
(
Get Free Report)
Savaria Corporation provides accessibility solutions for the elderly and physically challenged people in Canada, the United States, Europe, and internationally. The company operates in two segments, Accessibility and Patient Care. The Accessibility segment designs, manufactures, distributes, and installs a portfolio of accessibility products, including commercial and home elevators, stairlifts, platform lifts, and wheelchair lowered-floor accessible conversions for selected brands of minivans, personal, residential, or commercial applications.
See Also
Before you consider Savaria, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Savaria wasn't on the list.
While Savaria currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.